Evidence map›Paper›PMID 33194084›Full record

ArticleAmerican journal of translational research2020

Effect of

Haorui Zhang, Yutao Li, Shicheng Guo, Yi Wang, Haijian Wang, Daru Lu, Jiucun Wang, Li Jin, Gengxi Jiang, Junjie Wu and 2 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Genetic signatures ofOncology research · 2025
    Article
  5. Article
  6. Article
  7. Significance ofInternational journal of medical sciences · 2024
    Article
  8. Genetic variants inCancer innovation · 2022
    Article
  9. The Association ofJournal of Cancer · 2022
    Article
  10. Article
  11. Associations BetweenFrontiers in oncology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Haorui ZhangCompany 6 of Basic Medical Science, Navy Military Medical University Shanghai, China.
Yutao LiState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University Shanghai, China.
Shicheng GuoDepartment of Medical Genetics, School of Medicine and Public Health, University of Wisconsin-Madison Madison, WI, USA.
Yi WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University Shanghai, China.
Haijian WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University Shanghai, China.
Daru LuState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University Shanghai, China.
Jiucun WangState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University Shanghai, China.
Li JinState Key Laboratory of Genetic Engineering, Collaborative Innovation Center for Genetics and Development, School of Life Sciences, Fudan University Shanghai, China.
Gengxi JiangDepartment of Thoracic Surgery, Navy Military Medical University Affiliated Changhai Hospital Shanghai, China.
Junjie WuDepartment of Respiratory and Critical Care Medicine, Navy Military Medical University Affiliated Changhai Hospital Shanghai, China.
Yiping HanDepartment of Respiratory and Critical Care Medicine, Navy Military Medical University Affiliated Changhai Hospital Shanghai, China.
Juhong LiCenter of Physical Examination, Navy Military Medical University Affiliated Changhai Hospital Shanghai, China.
Fudan University · CNSecond Military Medical University · CNMarshfield Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe 5-year survival rate of patients with lung cancer in China is < 20%, and predicting their prognosis is difficult. Here, we investigated the association between two common non-synonymous single-nucleotide polymorphisms (SNPs) in the excision repair cross-complementing 2 (

methodsGenomic DNA was extracted from the blood samples of 839 patients with lung cancer and genotyped using the SNPscan technique. The association between patient prognosis and the

resultsThe presence of

conclusion

Indexed as

ERCC2lung cancerprognosisrs13181rs1799793single-nucleotide polymorphism

Identifiers

PMID33194084
PMCPMC7653631
OpenAlexW3103250686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.